Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS.

PubWeight™: 2.98‹?› | Rank: Top 1%

🔗 View Article (PMC 2685533)

Published in Genes Dev on May 15, 2009

Authors

Marta Barradas1, Emma Anderton, Juan Carlos Acosta, Side Li, Ana Banito, Marc Rodriguez-Niedenführ, Goedele Maertens, Michaela Banck, Ming-Ming Zhou, Martin J Walsh, Gordon Peters, Jesús Gil

Author Affiliations

1: Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College, London W12 0NN, United Kingdom.

Articles citing this

(truncated to the top 100)

The essence of senescence. Genes Dev (2010) 8.21

Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell (2010) 6.94

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer (2010) 6.27

Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev (2009) 4.69

The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol (2010) 4.66

Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol (2012) 3.40

A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol (2013) 2.98

mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype. Nat Cell Biol (2015) 2.48

Cellular senescence and its effector programs. Genes Dev (2014) 2.37

The circadian molecular clock creates epidermal stem cell heterogeneity. Nature (2011) 2.34

What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer. Genes Dev (2013) 2.31

Histone lysine demethylases as targets for anticancer therapy. Nat Rev Drug Discov (2013) 2.16

Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell (2012) 2.15

Cellular senescence and tumor suppressor gene p16. Int J Cancer (2011) 2.14

Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol Cell (2012) 2.02

Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat Rev Cancer (2010) 1.93

Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases. Cold Spring Harb Symp Quant Biol (2011) 1.81

UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. PLoS Genet (2012) 1.67

Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. J Cell Biol (2009) 1.66

Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics (2010) 1.63

The histone demethylase UTX enables RB-dependent cell fate control. Genes Dev (2010) 1.62

Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci U S A (2011) 1.53

Targeting Histone Demethylases: A New Avenue for the Fight against Cancer. Genes Cancer (2011) 1.47

Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature (2014) 1.47

Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep (2010) 1.38

Lysosome-mediated processing of chromatin in senescence. J Cell Biol (2013) 1.38

A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell (2013) 1.37

V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med (2010) 1.36

A complex Polycomb issue: the two faces of EZH2 in cancer. Genes Dev (2012) 1.32

Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog (2010) 1.27

Cancer associated human papillomaviruses. Curr Opin Virol (2012) 1.25

Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc Natl Acad Sci U S A (2011) 1.18

Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. Nat Commun (2014) 1.17

Histone demethylase KDM6B promotes epithelial-mesenchymal transition. J Biol Chem (2012) 1.16

Jmjd3 inhibits reprogramming by upregulating expression of INK4a/Arf and targeting PHF20 for ubiquitination. Cell (2013) 1.16

Jarid2 regulates mouse epidermal stem cell activation and differentiation. EMBO J (2011) 1.14

The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies. Oncotarget (2014) 1.12

H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependency. EMBO J (2011) 1.12

BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res (2012) 1.10

Activation of Bmp2-Smad1 signal and its regulation by coordinated alteration of H3K27 trimethylation in Ras-induced senescence. PLoS Genet (2011) 1.10

The molecular balancing act of p16(INK4a) in cancer and aging. Mol Cancer Res (2013) 1.08

The roles of Jumonji-type oxygenases in human disease. Epigenomics (2014) 1.05

EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence. Epigenetics Chromatin (2009) 1.05

p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb. Cancer Res (2011) 1.04

Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines. Proc Natl Acad Sci U S A (2013) 1.04

Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization. PLoS One (2012) 1.02

p53 interaction with JMJD3 results in its nuclear distribution during mouse neural stem cell differentiation. PLoS One (2011) 1.00

Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells. Mol Pharmacol (2011) 0.99

Ras-induced senescence and its physiological relevance in cancer. Curr Cancer Drug Targets (2010) 0.99

The histone demethylase Jarid1b (Kdm5b) is a novel component of the Rb pathway and associates with E2f-target genes in MEFs during senescence. PLoS One (2011) 0.98

The histone methyltransferase Dot1/DOT1L as a critical regulator of the cell cycle. Cell Cycle (2014) 0.97

Expression and significance of histone H3K27 demethylases in renal cell carcinoma. BMC Cancer (2012) 0.97

Stage-dependent and locus-specific role of histone demethylase Jumonji D3 (JMJD3) in the embryonic stages of lung development. PLoS Genet (2014) 0.97

Ras-induced changes in H3K27me3 occur after those in transcriptional activity. PLoS Genet (2013) 0.96

A novel zinc finger protein Zfp277 mediates transcriptional repression of the Ink4a/arf locus through polycomb repressive complex 1. PLoS One (2010) 0.95

Novel ARF/p53-independent senescence pathways in cancer repression. J Mol Med (Berl) (2011) 0.95

KDM6 demethylase independent loss of histone H3 lysine 27 trimethylation during early embryonic development. PLoS Genet (2014) 0.95

MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells. Stem Cells (2014) 0.93

Epigenetics and cancer. J Appl Physiol (1985) (2010) 0.93

Combined modulation of polycomb and trithorax genes rejuvenates β cell replication. J Clin Invest (2013) 0.92

EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection. Front Genet (2013) 0.91

Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation. Nat Commun (2014) 0.91

ATF4-dependent regulation of the JMJD3 gene during amino acid deprivation can be rescued in Atf4-deficient cells by inhibition of deacetylation. J Biol Chem (2012) 0.91

Genome-wide co-localization of Polycomb orthologs and their effects on gene expression in human fibroblasts. Genome Biol (2014) 0.90

Postnatal development, maturation and aging in the mouse cochlea and their effects on hair cell regeneration. Hear Res (2012) 0.89

Tetrahymena thermophila JMJD3 homolog regulates H3K27 methylation and nuclear differentiation. Eukaryot Cell (2012) 0.89

HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia. Genes Dev (2014) 0.89

Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation. EMBO J (2013) 0.89

Hypoxia and senescence: the impact of oxygenation on tumor suppression. Mol Cancer Res (2011) 0.89

Real-time in vivo imaging of p16gene expression: a new approach to study senescence stress signaling in living animals. Cell Div (2010) 0.89

HIF-1-dependent induction of Jumonji domain-containing protein (JMJD) 3 under hypoxic conditions. Mol Cells (2014) 0.88

The canonical NF-κB pathway differentially protects normal and human tumor cells from ROS-induced DNA damage. Cell Signal (2012) 0.87

Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression. Pigment Cell Melanoma Res (2011) 0.87

Deregulation of the Ras-Erk Signaling Axis Modulates the Enhancer Landscape. Cell Rep (2015) 0.87

The histone lysine demethylase JMJD3/KDM6B is recruited to p53 bound promoters and enhancer elements in a p53 dependent manner. PLoS One (2014) 0.86

Chromatin remodeling in cancer: a gateway to regulate gene transcription. Mol Oncol (2012) 0.86

The histone demethylase jumonji coordinates cellular senescence including secretion of neural stem cell-attracting cytokines. Mol Cancer Res (2015) 0.86

MLL1 is essential for the senescence-associated secretory phenotype. Genes Dev (2016) 0.85

ROS, Cell Senescence, and Novel Molecular Mechanisms in Aging and Age-Related Diseases. Oxid Med Cell Longev (2016) 0.85

A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity. Nat Commun (2015) 0.84

The nuclear receptor NR2E1/TLX controls senescence. Oncogene (2014) 0.83

Chromatin remodeling, DNA damage repair and aging. Curr Genomics (2012) 0.82

Cell cycle progression in response to oxygen levels. Cell Mol Life Sci (2014) 0.82

DNA methylation-mediated repression of miR-941 enhances lysine (K)-specific demethylase 6B expression in hepatoma cells. J Biol Chem (2014) 0.82

Biochemical and functional interactions of human papillomavirus proteins with polycomb group proteins. Viruses (2013) 0.81

Contrasting behavior of the p18INK4c and p16INK4a tumor suppressors in both replicative and oncogene-induced senescence. Cancer Res (2011) 0.80

The localization of histone H3K27me3 demethylase Jmjd3 is dynamically regulated. Epigenetics (2014) 0.80

Mechanisms of histone H3 lysine 27 trimethylation remodeling during early mammalian development. Epigenetics (2012) 0.79

Human papillomavirus carcinogenesis: an identity crisis in the retinoblastoma tumor suppressor pathway. J Virol (2015) 0.79

H3K27 demethylase, JMJD3, regulates fragmentation of spermatogonial cysts. PLoS One (2013) 0.79

Histone methylation and aging: lessons learned from model systems. Biochim Biophys Acta (2014) 0.79

Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved. Oncotarget (2014) 0.79

Tumor suppression by the histone demethylase UTX. Cell Cycle (2010) 0.78

Chromatin: a molecular interface between cancer and aging. Curr Opin Genet Dev (2010) 0.78

JMJD3 promotes SAHF formation in senescent WI38 cells by triggering an interplay between demethylation and phosphorylation of RB protein. Cell Death Differ (2015) 0.78

Maintaining CD4-CD8 lineage integrity in T cells: where plasticity serves versatility. Semin Immunol (2011) 0.78

Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers. Cancer Biol Ther (2012) 0.78

Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs. Haematologica (2016) 0.77

Hypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases. Aging Dis (2016) 0.77

CBX7 and miR-9 are part of an autoregulatory loop controlling p16(INK) (4a). Aging Cell (2015) 0.77

Articles cited by this

The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature (2002) 18.30

BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature (2005) 16.87

Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol (2007) 16.55

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell (1997) 12.41

Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer (2006) 11.48

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J (2003) 9.55

UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature (2007) 8.32

Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 7.65

Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science (2007) 7.41

Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature (2001) 7.06

The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev (2007) 6.77

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev (2007) 6.71

A histone H3 lysine 27 demethylase regulates animal posterior development. Nature (2007) 6.57

The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell (2007) 6.07

Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol (2006) 6.06

Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol Cell Biol (2006) 5.74

Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev (2008) 5.25

SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature (2007) 4.33

Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc Natl Acad Sci U S A (2007) 4.20

Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature (2001) 3.57

Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev (2008) 3.32

Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res (2005) 3.30

Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer (2006) 3.23

INK4a/ARF: a multifunctional tumor suppressor locus. Mutat Res (2005) 3.08

The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev (2009) 3.04

Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol (2003) 2.96

The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer (2006) 2.85

SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus. Mol Cell Biol (2008) 2.14

The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene (2004) 2.14

JMJD3 is a histone H3K27 demethylase. Cell Res (2007) 1.97

The histone H3 lysine 27-specific demethylase Jmjd3 is required for neural commitment. PLoS One (2008) 1.57

Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell (2003) 1.38

Inducible activation of Ras and Raf in adult epidermis. Cancer Res (2003) 1.29

Contribution of p16(INK4a) to replicative senescence of human fibroblasts. Exp Cell Res (2004) 1.22

Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1. J Biol Chem (2004) 1.16

Articles by these authors

Tumour biology: senescence in premalignant tumours. Nature (2005) 10.15

Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 7.65

Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell (2010) 6.94

Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol (2006) 6.06

Structure and conserved RNA binding of the PAZ domain. Nature (2003) 5.28

HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem (2002) 4.91

Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev (2009) 4.69

Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol (2006) 4.55

Glycolytic enzymes can modulate cellular life span. Cancer Res (2005) 3.78

Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol Cell Biol (2008) 3.74

Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol Cell (2007) 3.51

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol (2012) 3.40

A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol (2013) 2.98

PHD domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell (2007) 2.77

The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood (2007) 2.58

High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci U S A (2014) 2.50

Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol Cell (2004) 2.43

Structure and regulation of MAPK phosphatases. Cell Signal (2004) 2.42

CCAAT displacement protein/cut homolog recruits G9a histone lysine methyltransferase to repress transcription. Proc Natl Acad Sci U S A (2004) 2.38

Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol Cell (2002) 2.20

Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75. Nat Struct Mol Biol (2005) 2.17

Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b. Nature (2010) 2.02

A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res (2006) 2.02

The role of human bromodomains in chromatin biology and gene transcription. Curr Opin Drug Discov Devel (2009) 1.99

ESCs require PRC2 to direct the successful reprogramming of differentiated cells toward pluripotency. Cell Stem Cell (2010) 1.98

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol (2006) 1.98

INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J (2002) 1.96

Role of polycomb group proteins in stem cell self-renewal and cancer. DNA Cell Biol (2005) 1.89

BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle (2012) 1.88

Structural basis of site-specific histone recognition by the bromodomains of human coactivators PCAF and CBP/p300. Structure (2008) 1.86

The PHD finger: a versatile epigenome reader. Trends Biochem Sci (2011) 1.81

MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiation. Cell Stem Cell (2012) 1.72

A dimeric viral SET domain methyltransferase specific to Lys27 of histone H3. Nat Struct Biol (2003) 1.67

Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. J Biol Chem (2012) 1.66

Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci U S A (2007) 1.65

Myc confers androgen-independent prostate cancer cell growth. J Clin Invest (2003) 1.65

Epigenetic regulation of the INK4b-ARF-INK4a locus: in sickness and in health. Epigenetics (2010) 1.63

CBX7 controls the growth of normal and tumor-derived prostate cells by repressing the Ink4a/Arf locus. Oncogene (2005) 1.63

Immortalisation and transformation revisited. Curr Opin Genet Dev (2002) 1.57

Solution structure of the MAPK phosphatase PAC-1 catalytic domain. Insights into substrate-induced enzymatic activation of MKP. Structure (2003) 1.54

A phosphorylated form of Mel-18 targets the Ring1B histone H2A ubiquitin ligase to chromatin. Mol Cell (2007) 1.52

Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J (2002) 1.49

Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locus. PLoS One (2009) 1.47

Krüppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1. J Biol Chem (2005) 1.46

BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy. Cancer Res (2013) 1.43

Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes. J Biol Chem (2011) 1.43

The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. J Clin Endocrinol Metab (2008) 1.42

Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog (2009) 1.39

Induced pluripotent stem cells and senescence: learning the biology to improve the technology. EMBO Rep (2010) 1.38

Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes. Cancer Cell (2003) 1.38

Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol Cell Biol (2002) 1.36

A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. Chem Biol (2011) 1.35

Structure and site-specific recognition of histone H3 by the PHD finger of human autoimmune regulator. Structure (2009) 1.35

Ncoa3 functions as an essential Esrrb coactivator to sustain embryonic stem cell self-renewal and reprogramming. Genes Dev (2012) 1.34

Epigenetic transcriptional repression of cellular genes by a viral SET protein. Nat Cell Biol (2008) 1.34

Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol Cell (2005) 1.34

Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation. Proc Natl Acad Sci U S A (2012) 1.33

Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. Cell Stem Cell (2011) 1.33

Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression. Cell Stem Cell (2012) 1.33

Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing. Nat Struct Mol Biol (2008) 1.32

Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res (2011) 1.31

Immortalization of primary human prostate epithelial cells by c-Myc. Cancer Res (2005) 1.30

Structural insights of the specificity and catalysis of a viral histone H3 lysine 27 methyltransferase. J Mol Biol (2006) 1.30

Keeping it in the family: diverse histone recognition by conserved structural folds. Crit Rev Biochem Mol Biol (2010) 1.29

Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor. EMBO J (2010) 1.28

G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta. J Biol Chem (2008) 1.28

Structure and hemimethylated CpG binding of the SRA domain from human UHRF1. J Biol Chem (2008) 1.26

Senescence: a new weapon for cancer therapy. Trends Cell Biol (2012) 1.25

Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem Biol (2006) 1.25

Contribution of p16(INK4a) to replicative senescence of human fibroblasts. Exp Cell Res (2004) 1.22

DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells. Mol Cell (2011) 1.21

Regulation of Kruppel-like factor 6 tumor suppressor activity by acetylation. Cancer Res (2005) 1.20

A role for CXCR2 in senescence, but what about in cancer? Cancer Res (2009) 1.19

Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J Am Chem Soc (2005) 1.18

p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. PLoS One (2010) 1.18

Control of senescence by CXCR2 and its ligands. Cell Cycle (2008) 1.17

Ligand-dependent activation of the farnesoid X-receptor directs arginine methylation of histone H3 by CARM1. J Biol Chem (2004) 1.16

p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression. J Natl Cancer Inst (2003) 1.16

CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol Cell Biol (2007) 1.16